The RNA binding protein RALY suppresses p53 activity and promotes lung tumorigenesis.

TL;DR: The study suggests that DNA methylation could serve as a valuable biomarker for assessing the ecotoxicological impact of Sb exposure and contributes to a better understanding of the toxicity mechanisms in aquatic environments caused potential pollutants.

TL;DR: In this paper , the authors explored the tumor microenvironment and discovered unique characteristics of microglia to interact with astrocytoma cells and promote proliferation and migration of collisions.

TL;DR: A novel mechanism by which O-GlcNAcylation/RALY/USP22 mRNA axis aggravates HCC cells proliferation and RALY-PROTACs as degraders of the RALY protein exhibit potential as therapeutic drugs for RALY-overexpressing HCC.

TL;DR: Researchers identified GTPBP4 as a key driver of in vitro oocyte development in prepubertal goats, enhancing developmental competence through cell cycle progression, organelle maturation, and mRNA translation, with implications for fertility preservation in humans and reproductive efficiency in domestic animals.

TL;DR: The p53 tumour-suppressor gene integrates numerous signals that control cell life and death, and the disruption of p53 has severe consequences when a highly connected node in the Internet breaks down.

TL;DR: It is proposed that the Mdm2-promoted degradation of p53 provides a new mechanism to ensure effective termination of the p53 signal.

TL;DR: It is shown that interaction with Mdm2 can also result in a large reduction in p53 protein levels through enhanced proteasome-dependent degradation, which may contribute to the maintenance of low p53 concentrations in normal cells.

TL;DR: Control of p53's transcriptional activity is crucial for determining which p53 response is activated, a decision that must be understood if the next generation of drugs that selectively activate or inhibit p53 are to be exploited efficiently.